Royal Fund Management, LLC Johnson & Johnson Call Options Transaction History

Royal Fund Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 08, 2024	BUY	$145.48 - $167.38 $101,836 - $117,166	700 New	700 $113,000
Q1 2024 Apr 11, 2024	SELL	$155.22 - $162.74 $15,522 - $16,274	-100 Reduced 11.11%	800 $126,000
Q4 2023 Feb 06, 2024	BUY	$145.6 - $158.88 $131,040 - $142,992	900 New	900 $141,000
Q2 2023 Jul 12, 2023	BUY	$154.35 - $166.11 $108,045 - $116,277	700 New	700 $115,000
Q4 2022 Jan 20, 2023	BUY	$160.2 - $179.79 $32,039 - $35,958	200 New	200 $0

4,271

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Royal Fund Management, LLC with notifications on news.